Join

Compare · ABCM vs CRL

ABCM vs CRL

Side-by-side comparison of Abcam plc (ABCM) and Charles River Laboratories International Inc. (CRL): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. ABCM focuses on Biotechnology: Biological Products (No Diagnostic Substances), while CRL focuses on Biotechnology: Commercial Physical & Biological Resarch.
  • CRL is the larger of the two at $8.91B, about 1.9x ABCM ($4.59B).
  • CRL has hit the wire 22 times in the past 4 weeks while ABCM has been quiet.
  • CRL has more recent analyst coverage (25 ratings vs 3 for ABCM).
MetricABCMCRL
Company
Abcam plc
Charles River Laboratories International Inc.
Price
$23.98+0.00%
$184.97+1.41%
Market cap
$4.59B
$8.91B
1M return
-
+21.40%
1Y return
-
+25.41%
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Commercial Physical & Biological Resarch
Exchange
NASDAQ
NYSE
IPO
2020
2000
News (4w)
0
22
Recent ratings
3
25
ABCM

Abcam plc

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

CRL

Charles River Laboratories International Inc.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts.

Latest ABCM

Latest CRL